𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protein kinase Cδ and caspase-3 modulate TRAIL-induced apoptosis in breast tumor cells

✍ Scribed by Shuping Yin; Seema Sethi; Kaladhar B. Reddy


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
337 KB
Volume
111
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This report describes that protein kinase C delta (PKCδ) overexpression prevents TRAIL‐induced apoptosis in breast tumor cells; however, the regulatory mechanism(s) involved in this phenomenon is(are) incompletely understood. In this study, we have shown that TRAIL‐induced apoptosis was significantly inhibited in PKCδ overexpressing MCF‐7 (MCF7/PKCδ) cells. Our data reveal that PKCδ inhibits caspase‐8 activation, a first step in TRAIL‐induced apoptosis, thus preventing TRAIL‐induced apoptosis. Inhibition of PKCδ using rottlerin or PKCδ siRNA reverses the inhibitory effect of PKCδ on caspase‐8 activation leading to TRAIL‐induced apoptosis. To determine if caspase‐3‐induced PKCδ cleavage reverses its inhibition on caspase‐8, we developed stable cell lines that either expresses wild‐type PKCδ (MCF‐7/cas‐3/PKCδ) or caspase‐3 cleavage‐resistant PKCδ mutant (MCF‐7/cas‐3/PKCδ mut) utilizing MCF‐7 cells expressing caspase‐3. Cells that overexpress caspase‐3 cleavage‐resistant PKCδ mutant (MCF‐7/cas‐3/PKCδmut) significantly inhibited TRAIL‐induced apoptosis when compared to wild‐type PKCδ (MCF‐7/cas‐3/PKCδ) expressing cells. In MCF‐7/cas‐3/PKCδmut cells, TRAIL‐induced caspase‐8 activation was blocked leading to inhibition of apoptosis when compared to wild‐type PKCδ (MCF‐7/cas‐3/PKCδ) expressing cells. Together, these results strongly suggest that overexpression of PKCδ inhibits caspase‐8 activation leading to inhibition of TRAIL‐induced apoptosis and its inhibition by rottlerin, siRNA, or cleavage by caspase‐3 sensitizes cells to TRAIL‐induced apoptosis. Clinically, PKCδ overexpressing tumors can be treated with a combination of PKCδ inhibitor(s) and TRAIL as a new treatment strategy. J. Cell. Biochem. 111: 979–987, 2010. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Involvement of caspase-3 and p38 mitogen
✍ Weiguo Zou; Jiping Zeng; Ming Zhuo; Weijing Xu; Lanying Sun; Jinxing Wang; Xinyu 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Our previous study showed that cobalt chloride (CoCl~2~) could induce PC12 cell apoptosis and that the CoCl~2~‐treated PC12 cells may serve as a simple in vitro model for the study of the mechanism of hypoxia‐linked neuronal disorders. The aim of this study is to elucidate the mechanism

Protein kinase C-β, fibronectin, α5β1-in
✍ Amale Laouar; David Glesne; Eliezer Huberman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract The human myeloid HL‐60 cell line and its cell variant HL‐525 were used to study signaling events leading to apoptosis induction by phorbol 12‐myristate 13‐acetate (PMA), an activator of protein kinase C (PKC) enzymes. Unlike parental cells, HL‐525 cells are PKC‐β deficient and resistan

Potent stimulation of large-conductance
✍ Sheng-Nan Wu; Ya-Jean Wang; Ming-Wei Lin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract The effects of rottlerin, a known inhibitor of protein kinase C‐δ activation, on ion currents were investigated in pituitary tumor (GH~3~) cells. Rottlerin (0.3–100 µM) increased the amplitude of Ca^2+^‐activated K^+^ current (I~K(Ca)~) in a concentration‐dependent manner with an EC~50~